Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Serine in Amyotrophic Lateral Sclerosis
NCT03580616Phase 2Terminated
- Start
- Oct 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-serine in amyotrophic lateral sclerosis (ALS). Started Oct 2018; status: terminated.
02
Drugs
l-serine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03580616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580616.